5
Views
5
CrossRef citations to date
0
Altmetric
Original Papers

The Incidence of Familial Nonmedullary Thyroid Cancer in a Large Case Series

, , , , , , , , & show all
Pages 328-332 | Published online: 11 Mar 2016

References

  • Hoermann R., Quadbeck B. Medullary thyroid carcinoma. Oncol Pract, 1999, 1: 8–10.
  • Nemec J., Soumar J., Zamrazil V., Pohunkova D., Motlik K., Mirejovsky P. Familial occurrence of differentiated (non-medullary) thyroid cancer. Oncology, 1975, 32: 151–7.
  • Lote K., Andersen K., Nordal E., Brennhovd I. O. Familial occurrence of papillary thyroid carcinoma. Cancer (Phila.), 1980, 46: 1291–7.
  • Johnson E. R., Gardner D. M. Familial occurrence of non-medullary thyroid carcinoma. Experience at the university of Missouri Health Sciences Center. Mo Med, 1981, 78: 647–9.
  • Christensen S., Ljungberg O. Familial occurrence of papillary thyroid carcinoma. Br J Surg, 1983, 70: 508–9.
  • Stoffer S., VanDyke D., Bach J., Szpunar W., Weiss L. Familial papillary carcinoma of the thyroid. Am J Med Genet, 1986, 25: 775–82.
  • Ozaki O., Ito K., Kobayashi K., Suzuki A., Manabe Y., Hosoda Y. Familial occurrence of differentiated, nonmedullary thyroid carcinoma. World J Surg, 1988, 12: 565–71.
  • Fischer D., Groves M., Thomas S., Johnson P. Papillary carcinoma of the thyroid: additional evidence in support of a familial component. Cancer Invest, 1989, 7: 323–5.
  • Ron E., Kleinerman R., LiVolsi v., Fraumeni J. Familial non-medullary thyroid cancer. Oncology, 1991, 48: 309–11.
  • Grossman R. F., Tu S. H., Duh Q. Y., Siperstein A. E., Novosolov F., Clark O. H. Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg, 1996, 130: 892–7.
  • Malchoff C. D., Malchoff D. M. Familial nonmedullary thyroid carcinoma. Cancer Control, 2006, 13: 106–10.
  • Brunaud L., Zarnegar R., Wada N. et al. Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial nonmedullary thyroid cancer. Thyroid, 2003, 13: 621–29.
  • Ruben Harach H. Familial nonmedullary thyroid neoplasia. Endocr Pathol, 2001, 12: 97–112.
  • Loh K. C. Familial nonmedullary thyroid carcinoma: a metareview of case series. Thyroid, 1997, 7: 107–13.
  • Hemminki K., Eng C., Chen B. Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab, 2005, 90: 5747–53.
  • Alsanea O. Familial nonmedullary thyroid cancer. Curr Treat Options Oncol, 2000, 1: 345–51.
  • Uchino S., Noguchi S., Kawamoto H., Yamashita H., Watanabe S., Shuto S. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg, 2002, 26: 897–902.
  • Vriens M. R., Sabanci U., Epstein H. D. et al. Reliability of fine-needle aspiration in patients with familial nonmedullary thyroid cancer. Thyroid, 1999, 9: 1011–16.
  • Sippel R. S., Caron N. R., Clark O. H. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg, 2007, 31: 924–33.
  • Triponez F., Wong M., Sturgeon C. et al. Does familial nonmedullary thyroid cancer adversely affect survival ? World J Surg, 2006, 30: 787–93.
  • Sturgeon C., Clark O. H. Familial nonmedullary thyroid cancer. Thyroid, 2005, 15: 588–93.
  • Uchino S., Noguchi S., Yamashita H. et al. Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma. World J Surg, 2004, 28: 1099–102.
  • Dahia P. L., Marsh D. J., Zheng Z. et al. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res, 1997, 57: 4710–13.
  • Plail R. O., Bussey H. J., Glazer G., Thomson J. P. Adenomatous polyposis: An association with carcinoma of the thyroid. Br J Surg, 1987, 74: 77–80.
  • McKay J. D., Lesuer F., Jonard L. et al. Localisation of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet, 2001, 69: 440–46.
  • Kraimps J. L., Canzain F., Jost C. et al. Mapping of gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome, 19 and exclusion of JUN B as candidate gene. Surgery, 1999, 126: 1188–94.
  • Lesueur F., Stark M., Tocco T. et al. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab, 1999, 84: 2157–62.
  • Tsilchorozidou T., Vafiadou E., Yovos J. G. et al. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci. Thyroid, 2005, 15: 1349–54.
  • Xing M. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Clin Endocrinol (Oxf), 2005, 63: 263–6.
  • Charkes N. D. On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid, 2006, 16: 520–1.
  • Frich L., Glattre E., Akslen L. A. Familial occurrence of non-medullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norw. Cancer Epidemiol Biomarkers Prev, 2001, 10: 113–7.
  • Malchoff C. D., Malchoff D. M. Familial nonmedullary thyroid carcinoma. Semin Surg Oncol, 1999, 16: 16–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.